Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

|Videos|March 1, 2022

Deep Dive into Facial Plastic Surgery Trends

Author(s)Linda Stocum, Associate Editor

In a follow up interview about the results from the American Academy of Facial Plastic and Reconstructive Surgery annual survey AAFPRS president Corey S. Maas, MD, sits down to talk in depth details about the outcomes.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Michael Gold, MD, on Microneedling Optimization and Post-Procedure Innovation

ByMichael Gold, MD,Marie Bosslett, Assistant Editor

June 3rd 2026

Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen

ByMichael Gold, MD,Marie Bosslett, Assistant Editor

June 2nd 2026

Why Dermatology Practices Miss Revenue That’s Already Theirs

ByHarparam Sandhu, MD

June 1st 2026

The Aesthetic Edge: May 2026

ByMarie Bosslett, Assistant Editor

May 28th 2026

Stellar M22 Platform Demonstrates High Patient Satisfaction and Uniform Results in New Study

ByIsabella Camacho-Hubbard, MD,Marie Bosslett, Assistant Editor

May 25th 2026

Latest CME

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Trending on Dermatology Times

Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen

Social Media Mythbusters: Hypochlorous Acid Sprays

Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy

Topical GX-03 Hits 92.6% EASI-50 at Week 4 in Phase 2 AD Interim

SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome